NCT07020390 Effect of Anesthesia Techniques on Quality of Recovery Scores in HOLEP Surgery
| NCT ID | NCT07020390 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TC Erciyes University |
| Condition | HoLEP |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2025-06-20 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2025-06-20 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational study is to evaluate the effects of different anesthesia techniques on the quality of recovery (QoR) and patient satisfaction in male patients, typically older adults with benign prostatic hyperplasia, undergoing Holmium Laser Enucleation of the Prostate (HoLEP). Participants will undergo HoLEP surgery under one of three anesthesia techniques-general, spinal, or combined spinal-epidural anesthesia-and will complete the QoR-40 questionnaire both before and after the surgery.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for HOLEP surgery due to benign prostatic hyperplasia. * Patients who consent to participate in the study. Exclusion Criteria: * Refusal to participate in the study * Presence of cognitive impairment * Use of psychoactive medications * Failure of the intraoperative anesthesia technique and necessity to change the anesthesia method * Requirement for reoperation or admission to the intensive care unit * Voluntary withdrawal from the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07020390 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying HoLEP. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07020390 currently recruiting?
Yes, NCT07020390 is actively recruiting participants. Contact the research team at gamzetalih@gmail.com for enrollment information.
Where is the NCT07020390 trial being conducted?
This trial is being conducted at Melikgazi, Turkey (Türkiye).
Who is sponsoring the NCT07020390 clinical trial?
NCT07020390 is sponsored by TC Erciyes University. The trial plans to enroll 450 participants.